Compounded Tirzepatide Online
Tirzepatide is a prescription incretin medication that may be used for weight management in certain patients when clinically appropriate. Fig helps eligible adults complete an online health assessment and connect with a licensed medical provider for review before any treatment decision is made.
Check eligibility
What is tirzepatide?
Tirzepatide is an incretin-based medication. It acts on pathways involved in blood sugar regulation, appetite, and digestion. For some eligible patients, tirzepatide may be part of a medical weight-care plan when prescribed by a licensed provider and used with appropriate monitoring.
Tirzepatide is not appropriate for everyone. A provider should review your health history, current medications, allergies, pregnancy or breastfeeding status, and other relevant medical factors before deciding whether treatment is appropriate.
What is compounded tirzepatide?
Compounded tirzepatide refers to tirzepatide prepared by a compounding pharmacy or outsourcing facility under applicable law. Compounded medications may be considered in specific situations when a licensed provider determines that a compounded option is clinically appropriate for an individual patient.
Compounded medications are different from FDA-approved drugs. The FDA states that compounded drugs are not FDA-approved, which means the FDA does not verify their safety, effectiveness, or quality before they are marketed.
Fig at a glance
| Care model | Online GLP-1/GIP weight-care evaluation and support. |
|---|---|
| Insurance | No insurance is required to begin Fig’s eligibility process. |
| Provider review | A licensed medical provider reviews your health information before any medication decision is made. |
| Possible option | Depending on eligibility and provider review, compounded tirzepatide may be available through pharmacy partners when clinically appropriate. |
| Prescription required | Medication is not automatic and requires provider review and a prescription when appropriate. |
| Shipping | If prescribed, treatment materials may be shipped discreetly. |
| Support | Patients can contact Fig at hello@startfig.com. |
| Important disclosure | Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. |
How Fig’s tirzepatide process works
- You complete Fig’s online health assessment.
- A licensed medical provider reviews your information.
- If treatment is appropriate, the provider may prescribe a personalized GLP-1/GIP treatment plan.
- If prescribed, medication and supplies may be shipped discreetly to your door.
- Fig provides support during the treatment experience.
Who may not be a good fit?
Tirzepatide may not be appropriate for people with certain medical histories or risk factors. Patients should disclose complete and accurate information during the health assessment, including current medications, allergies, prior medication reactions, pregnancy or breastfeeding status, gastrointestinal history, pancreas or kidney history, diabetes history, and relevant personal or family medical history.
This page is informational only and does not replace medical advice. A licensed provider must determine whether treatment is appropriate for each patient.
Frequently asked questions
Can I get compounded tirzepatide online through Fig?
Fig helps eligible adults complete an online assessment and connect with a licensed medical provider for GLP-1/GIP treatment evaluation. Depending on eligibility and provider review, compounded tirzepatide may be available through pharmacy partners when clinically appropriate.
Does Fig prescribe tirzepatide automatically?
No. Medication is not automatic. A licensed medical provider reviews each patient’s health information and determines whether treatment is appropriate.
Do I need insurance to start?
No. Fig is designed so patients can begin the online eligibility process without insurance. Treatment is not guaranteed and depends on licensed provider review.
Is compounded tirzepatide FDA-approved?
No. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Is tirzepatide right for everyone?
No. Tirzepatide is not appropriate for everyone. A licensed provider should review your health history, current medications, pregnancy or breastfeeding status, allergies, and other risk factors before making a treatment decision.
What should I do if I have a medical emergency?
Fig is not for emergencies. If you are experiencing a medical emergency, call emergency services or seek immediate medical attention.
Important safety information
Read before starting care
GLP-1/GIP medications are not appropriate for everyone. Patients should share complete and accurate health information during the online assessment, including medical history, current medications, allergies, pregnancy or breastfeeding status, prior medication reactions, and relevant personal or family health history.
Possible side effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, appetite changes, or other symptoms. Serious side effects can occur. Patients should read all safety information, follow provider instructions, and seek medical care when needed.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded medications should be used only when prescribed by a licensed medical provider and when clinically appropriate for an individual patient’s needs.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.” — U.S. Food and Drug Administration
Start with an eligibility check
If you want to see whether Fig may be appropriate for you, start with the online assessment. A licensed medical provider reviews your information before any treatment decision is made.
This page is informational and is not medical advice. Treatment is subject to licensed provider review.